Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -130000.00% is 743% below its 5-year average of -15429.30%, near the low end of its 5-year range (-130000.00%–0.00%).
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
-130000.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
-9809.09%
NET PROFIT MARGIN AVG 5Y
-15429.30%
NET PROFIT MARGIN AVG 10Y
-8612.27%
NET PROFIT MARGIN AVG 15Y
-4232.66%
NET PROFIT MARGIN AVG 20Y
-509.34%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-1225.30%
CURRENT VS 5Y AVG
-742.55%
CURRENT VS 10Y AVG
-1409.47%
CURRENT VS 15Y AVG
-2971.35%
CURRENT VS 20Y AVG
-25423.15%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 787 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Inovio Pharmaceuticals, Inc.
Market Cap
$79.46M
Net Profit Margin
-130000.00%
TTM Avg
0.00%
3Y Avg
-9809.09%
5Y Avg
-15429.30%
Market Cap
$79.04M
Net Profit Margin
-648.32%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$77.93M
Net Profit Margin
-55.03%
TTM Avg
-63.48%
3Y Avg
-81.34%
5Y Avg
-87.39%
Market Cap
$77.80M
Net Profit Margin
-155404.38%
TTM Avg
-155404.38%
3Y Avg
-155404.38%
5Y Avg
-155404.38%
Market Cap
$80.78M
Net Profit Margin
-430.43%
TTM Avg
-446.97%
3Y Avg
-347.08%
5Y Avg
-386.84%
Market Cap
$77.15M
Net Profit Margin
-47475.71%
TTM Avg
-41070.98%
3Y Avg
-27618.26%
5Y Avg
-38759.83%
Market Cap
$77.39M
Net Profit Margin
-210.75%
TTM Avg
-289.10%
3Y Avg
-513.23%
5Y Avg
-2388.54%
Market Cap
$81.86M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$76.19M
Net Profit Margin
-63.06%
TTM Avg
-90.45%
3Y Avg
-113.67%
5Y Avg
-137.76%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inovio Pharmaceuticals, Inc. (INO) | $79.46M | -130000.00% | 0.00% | -9809.09% | -15429.30% |
| Citius Oncology, Inc. (CTOR)vs › | $79.04M | -648.32% | 0.00% | 0.00% | 0.00% |
| Pulmonx Corporation (LUNG)vs › | $77.93M | -55.03% | -63.48% | -81.34% | -87.39% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.80M | -155404.38% | -155404.38% | -155404.38% | -155404.38% |
| Nutriband Inc. (NTRB)vs › | $80.78M | -430.43% | -446.97% | -347.08% | -386.84% |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | -47475.71% | -41070.98% | -27618.26% | -38759.83% |
| Hyperfine, Inc. (HYPR)vs › | $77.39M | -210.75% | -289.10% | -513.23% | -2388.54% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $81.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Outset Medical, Inc. (OM)vs › | $76.19M | -63.06% | -90.45% | -113.67% | -137.76% |
| SkinHealth Systems Inc. (SKIN)vs › | $76.14M | -9.79% | -5.93% | -6.23% | -32.51% |
Operating Margin
-132871.3%
Net Profit Margin
-130000.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -30140.48% |
| 2024-12-31 | -16566.39% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | -31993.31% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -24357.91% |
| 2023-09-30 | -8734.77% |
| 2023-06-30 | -15725.26% |
| 2023-03-31 | -35364.76% |
| 2022-12-31 | -43687.24% |
| 2022-09-30 | -412.75% |
| 2022-06-30 | -13831.97% |
| 2022-03-31 | -39720.77% |
| 2021-12-31 | -12745.28% |
| 2021-09-30 | -20627.17% |
| 2021-06-30 | -30107.31% |
| 2021-03-31 | -14658.91% |
| 2020-12-31 | -436.13% |
| 2020-09-30 | 8117.33% |
| 2020-06-30 | -48169.66% |
| 2020-03-31 | -2451.72% |
| 2019-12-31 | -13475.37% |
| 2019-09-30 | -2663.71% |
| 2019-06-30 | -21660.33% |
| 2019-03-31 | -1032.52% |
| 2018-12-31 | -1317.11% |
| 2018-09-30 | -1250.24% |
| 2018-06-30 | -27.16% |
| 2018-03-31 | -2114.93% |
| 2017-12-31 | -244.74% |
| 2017-09-30 | -1290.75% |
| 2017-06-30 | -46.44% |
| 2017-03-31 | -222.49% |
| 2016-12-31 | -308.12% |
| 2016-09-30 | -165.54% |
| 2016-06-30 | -301.50% |
| 2016-03-31 | -99.17% |
| 2015-12-31 | -302.45% |
| 2015-09-30 | 23.13% |
| 2015-06-30 | -118.19% |
| 2015-03-31 | -204.81% |
| 2014-12-31 | -301.63% |
| 2014-09-30 | -390.01% |
| 2014-06-30 | -281.75% |
| 2014-03-31 | -458.99% |
| 2013-12-31 | -888.35% |
| 2013-09-30 | -325.48% |
| 2013-06-30 | -1381.42% |
| 2013-03-31 | -607.75% |
| 2012-12-31 | -58.05% |
| 2012-09-30 | -774.79% |
| 2012-06-30 | -947.80% |
| 2012-03-31 | -487.56% |
| 2011-12-31 | -335.42% |
| 2011-09-30 | -172.20% |
| 2011-06-30 | -116.63% |
| 2011-03-31 | -77.69% |
| 2010-12-31 | -266.68% |
| 2010-09-30 | -110.47% |
| 2010-06-30 | -671.14% |
| 2010-03-31 | -167.01% |
| 2009-12-31 | -281.17% |
| 2009-09-30 | -80.85% |
| 2009-06-30 | -427.56% |
| 2009-03-31 | -937.74% |
| 2008-12-31 | -1094.01% |
| 2008-09-30 | -515.55% |
| 2008-06-30 | -606.87% |
| 2008-03-31 | -462.73% |
| 2007-12-31 | 58.91% |
| 2007-09-30 | -949.82% |
| 2007-06-30 | -901.89% |
| 2007-03-31 | -807.86% |
| 2006-12-31 | -221.17% |
| 2006-09-30 | -592.00% |
| 2006-06-30 | -460.06% |
| 2006-03-31 | -377.35% |
| 2005-12-31 | -366.03% |
| 2005-09-30 | -412.82% |
| 2005-06-30 | -72.20% |
| 2005-03-31 | -742.24% |
| 2004-12-31 | -699.13% |
| 2004-09-30 | -753.97% |
| 2004-06-30 | -2169.06% |
| 2004-03-31 | -2279.50% |
| 2003-12-31 | -4636.40% |
| 2003-09-30 | -7531.32% |
| 2003-06-30 | -15517.97% |
| 2003-03-31 | 1598.71% |
| 2002-12-31 | -2066.86% |
| 2002-09-30 | -2048.85% |
